Indefinite Delivery Contract SPE2DV17D1021

The federal contract IDV award SPE2DV17D1021 is a single-award Indefinite Delivery Contract (IDC) held by Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. This $4,999,999 IDC was awarded by the Defense Logistics Agency (DLA) to provide a wide range of medical and pharmaceutical products to support military treatment facilities and other Department of Defense (DoD) healthcare providers. The contract covers a broad spectrum of essential medical supplies, including surgical equipment, diagnostic tools, personal protective equipment, pharmaceuticals, and medical consumables under Federal Supply Group 46 and Federal Supply Class 6515. This flexible IDC vehicle allows the DLA to issue multiple delivery orders against the master contract, enabling rapid procurement of critical medical products for federal healthcare systems, particularly within the military and defense healthcare networks. Cardinal Health 200, LLC, as a major healthcare services and products company, has demonstrated its ability to reliably supply a diverse range of medical and pharmaceutical items to the government, leveraging its extensive distribution capabilities and expertise.

The parent company, Cardinal Health, Inc., also holds significant federal contract awards, including an Indefinite Delivery Contract with the Department of Veterans Affairs (VA) for the supply of radiopharmaceuticals used in medical imaging procedures. Additionally, the company's subsidiary, The Harvard Drug Group, L.L.C., secured a separate IDC with the VA National Acquisition Center for the supply of Lurasidone Hydrochloride tablets. These contract awards highlight Cardinal Health's strategic importance in maintaining the medical supply chain for various federal healthcare agencies, including the DoD, VA, and National Institutes of Health (NIH), by providing essential pharmaceutical and medical products.